Abstract
The senses are our window to the world, our interface with the habitat in which we live in and the basis for our communication with each other. Although sensory systems are not generally viewed as major targets of endocrine regulation, sensory development is profoundly influenced by thyroid hormone (T3) signalling. In this article, we discuss this developmental role of T3 and highlight the auditory system as the best-studied example of the interplay between systemic and local tissue mechanisms by which T3 stimulates the onset of sensory function. Several genes that mediate the action of T3 are known to promote sensory development in mice, including genes that encode T3 receptors and deiodinase enzymes that amplify or deplete levels of T3. We also discuss the current knowledge of sensory defects in human genetic disorders in which T3 signalling is impaired. As sensory input provides the only means of acquiring information from the environment, the stimulation of sensory development is one of the most fundamental functions of T3 signalling.
Key Points
-
An endocrine signal, T3, has considerable control over the development of hearing and other senses in humans and mammalian animal models
-
The exposure of immature sensory tissues to T3 is dynamically regulated by systemic availability of the hormone and by local mechanisms in target tissues
-
T3 is a coordinating signal for the late-stage maturation of the auditory system that promotes the onset of function
-
T3 signalling during the later stages of cochlear development complements other mechanisms of short-range signalling at earlier developmental stages
-
The sensitivity of sensory development to T3 suggests that the senses merit further investigation in human disorders resulting from disrupted T3 signalling
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parker, W. R. A cretin treated by thyroid extract. Br. Med. J. 1, 333 (1896).
Osler, W. in Transactions of the Congress of American Physicians and Surgeons 169–206 (The Congress, Michigan, USA, 1897).
Refetoff, S., DeWind, L. T. & DeGroot, L. J. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J. Clin. Endocrinol. Metab. 27, 279–294 (1967).
DeLong, G. R., Stanbury, J. B. & Fierro-Benitez, R. Neurological signs in congenital iodine-deficiency disorder (endemic cretinism). Dev. Med. Child Neurol. 27, 317–324 (1985).
Sap, J. et al. The c-erbA protein is a high affinity receptor for thyroid hormone. Nature 324, 635–640 (1986).
Weinberger, C. et al. The c-erb-A gene encodes a thyroid hormone receptor. Nature 324, 641–646 (1986).
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J. & Larsen, P. R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23, 38–89 (2002).
St Germain, D. L., Galton, V. A. & Hernandez, A. Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology 150, 1097–1107 (2009).
Brucker-Davis, F. et al. Prevalence and mechanisms of hearing loss in patients with resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 81, 2768–2772 (1996).
Ng, L. et al. A thyroid hormone receptor that is required for the development of green cone photoreceptors. Nat. Genet. 27, 94–98 (2001).
Gogakos, A. I., Duncan Bassett, J. H. & Williams, G. R. Thyroid and bone. Arch. Biochem. Biophys. 503, 129–136 (2010).
Pei, L. et al. Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome. Nat. Med. 17, 1466–1472 (2011).
Bernal, J. Thyroid hormone receptors in brain development and function. Nat. Clin. Pract. Endocrinol. Metab. 3, 249–259 (2007).
Sohmer, H. & Freeman, S. Functional development of auditory sensitivity in the fetus and neonate. J. Basic. Clin. Physiol. Pharmacol. 6, 95–108 (1995).
Moore, J. K. & Linthicum, F. H. Jr. The human auditory system: a timeline of development. Int. J. Audiol. 46, 460–478 (2007).
Katz, L. C. & Shatz, C. J. Synaptic activity and the construction of cortical circuits. Science 274, 1133–1138 (1996).
Hensch, T. K. Critical period regulation. Annu. Rev. Neurosci. 27, 549–579 (2004).
Goslings, B. M., Djokomoeljanto, R., Hoedijono, R., Soepardjo, H. & Querido, A. Studies on hearing loss in a community with endemic cretinism in Central Java, Indonesia. Acta Endocrinol. (Copenh.) 78, 705–713 (1975).
Deol, M. S. An experimental approach to the understanding and treatment of hereditary syndromes with congenital deafness and hypothyroidism. J. Med. Genet. 10, 235–242 (1973).
Uziel, A., Marot, M. & Rabie, A. Corrective effects of thyroxine on cochlear abnormalities induced by congenital hypothyroidism in the rat. II. Electrophysiological study. Dev. Brain Res. 19, 123–127 (1985).
Sprenkle, P. M., McGee, J., Bertoni, J. M. & Walsh, E. J. Consequences of hypothyroidism on auditory system function in Tshr mutant (hyt) mice. J. Assoc. Res. Otolaryngol. 2, 312–329 (2001).
Marovitz, W. F., Berryhill, B. H. & Peterson, R. R. Disruptions of bony labyrinth, ossicular chain and tympanic bullae in dwarf mice. Laryngoscope 78, 863–872 (1968).
Cordas, E. A. et al. Thyroid hormone receptors control developmental maturation of the middle ear and the size of the ossicular bones. Endocrinology 153, 1548–1560 (2012).
Dow-Edwards, D., Crane, A. M., Rosloff, B., Kennedy, C. & Sokoloff, L. Local cerebral glucose utilization in the adult cretinous rat. Brain Res. 373, 139–145 (1986).
Friauf, E. et al. Hypothyroidism impairs chloride homeostasis and onset of inhibitory neurotransmission in developing auditory brainstem and hippocampal neurons. Eur. J. Neurosci. 28, 2371–2380 (2008).
Bradley, D. J., Towle, H. C. & Young, W. S. 3rd . α and β thyroid hormone receptor (TR) gene expression during auditory neurogenesis: evidence for TR isoform-specific transcriptional regulation in vivo. Proc. Natl Acad. Sci. USA 91, 439–443 (1994).
Bradley, D. J., Towle, H. C. & Young, W. S. 3rd . Spatial and temporal expression of α- and β-thyroid hormone receptor mRNAs, including the β 2-subtype, in the developing mammalian nervous system. J. Neurosci. 12, 2288–2302 (1992).
Rüsch, A. et al. Retardation of cochlear maturation and impaired hair cell function caused by deletion of all known thyroid hormone receptors. J. Neurosci. 21, 9792–9800 (2001).
Griffith, A. J. et al. Knock-in mouse model for resistance to thyroid hormone (RTH): an RTH mutation in the thyroid hormone receptor beta gene disrupts cochlear morphogenesis. J. Assoc. Res. Otolaryngol. 3, 279–288 (2002).
Richter, C. P., Munscher, A., Santana Machado, D., Wondisford, F. E. & Ortiga-Carvalho, T. M. Complete activation of thyroid hormone receptor β by T3 is essential for normal cochlear function and morphology in mice. Cell Physiol. Biochem. 28, 997–1008 (2011).
Winter, H. et al. Thyroid hormone receptor α1 is a critical regulator for the expression of ion channels during final differentiation of outer hair cells. Histochem. Cell Biol. 128, 65–75 (2007).
Ferrara, A. M. et al. Homozygous thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: three new cases and review of the literature. J. Clin. Endocrinol. Metab. 97, 1328–1336 (2012).
Bochukova, E. et al. A mutation in the thyroid hormone receptor α gene. N. Engl. J. Med. 366, 243–249 (2012).
van Mullem, A. et al. Clinical phenotype and mutant TRα1. N. Engl. J. Med. 366, 1451–1453 (2012).
Itoh, Y. et al. Brain glucose utilization in mice with a targeted mutation in the thyroid hormone α or β receptor gene. Proc. Natl Acad. Sci. USA 98, 9913–9918 (2001).
Ruben, R. J. Development of the inner ear of the mouse: a radioautographic study of terminal mitoses. Acta Otolaryngol. Suppl. 220, 221–244 (1967).
Kelley, M. W. Regulation of cell fate in the sensory epithelia of the inner ear. Nat. Rev. Neurosci. 7, 837–849 (2006).
Li, D., Henley, C. M. & O'Malley, B. W. Jr. Distortion product otoacoustic emissions and outer hair cell defects in the hyt/hyt mutant mouse. Hear. Res. 138, 65–72 (1999).
Christ, S. et al. Hearing loss in athyroid pax8 knockout mice and effects of thyroxine substitution. Audiol. Neurootol. 9, 88–106 (2004).
Song, L., McGee, J. A. & Walsh, E. J. Consequences of combined maternal, fetal and persistent postnatal hypothyroidism on the development of auditory function in Tshrhyt mutant mice. Brain Res. 1101, 59–72 (2006).
Johnson, K. R. et al. Congenital hypothyroidism, dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2. Mol. Endocrinol. 21, 1593–1602 (2007).
Karolyi, I. J. et al. Dietary thyroid hormone replacement ameliorates hearing deficits in hypothyroid mice. Mamm. Genome 18, 596–608 (2007).
Van Middlesworth, L. & Norris, C. Audiogenic seizures and cochlear damage in rats after perinatal antithyroid treatment. Endocrinol. 106, 1686–1690 (1980).
Uziel, A. Periods of sensitivity to thyroid hormone during the development of the organ of Corti. Acta Otolaryngol. (Stockh.) 101, 23–27 (1986).
Rüsch, A., Erway, L., Oliver, D., Vennström, B. & Forrest, D. Thyroid hormone receptor β-dependent expression of a potassium conductance in inner hair cells at the onset of hearing. Proc. Natl Acad. Sci. USA 95, 15758–15762 (1998).
Brandt, N. et al. Thyroid hormone deficiency affects postnatal spiking activity and expression of Ca2+ and K+ channels in rodent inner hair cells. J. Neurosci. 27, 3174–3186 (2007).
Sendin, G., Bulankina, A. V., Riedel, D. & Moser, T. Maturation of ribbon synapses in hair cells is driven by thyroid hormone. J. Neurosci. 27, 3163–3173 (2007).
Mustapha, M. et al. Deafness and permanently reduced potassium channel gene expression and function in hypothyroid Pit1dw mutants. J. Neurosci. 29, 1212–1223 (2009).
Szarama, K. B., Gavara, N., Petralia, R. S., Chadwick, R. S. & Kelley, M. W. Thyroid hormone increases fibroblast growth factor receptor expression and disrupts cell mechanics in the developing organ of corti. BMC Dev. Biol. 13, 6 (2013).
Uziel, A., Pujol, R., Legrand, C. & Legrand, J. Cochlear synaptogenesis in the hypothyroid rat. Dev. Brain Res. 7, 295–301 (1983).
Cantos, R., Lopez, D. E., Merchan, J. A. & Rueda, J. Olivocochlear efferent innervation of the organ of corti in hypothyroid rats. J. Comp. Neurol. 459, 454–467 (2003).
Hinojosa, R. A note on development of Corti's organ. Acta Otolaryngol. 84, 238–251 (1977).
Lukashkin, A. N., Richardson, G. P. & Russell, I. J. Multiple roles for the tectorial membrane in the active cochlea. Hear. Res. 266, 26–35 (2010).
Shi, Y. B., Fu, L., Hsia, S. C., Tomita, A. & Buchholz, D. Thyroid hormone regulation of apoptotic tissue remodeling during anuran metamorphosis. Cell Res. 11, 245–252 (2001).
Takahashi, K. et al. Caspase-3-deficiency induces hyperplasia of supporting cells and degeneration of sensory cells resulting in the hearing loss. Brain Res. 894, 359–367 (2001).
Rau, A., Legan, P. K. & Richardson, G. P. Tectorin mRNA expression is spatially and temporally restricted during mouse inner ear development. J. Comp. Neurol. 405, 271–280 (1999).
Knipper, M. et al. Thyroid hormone-deficient period prior to the onset of hearing is associated with reduced levels of beta-tectorin protein in the tectorial membrane: implication for hearing loss. J. Biol. Chem. 276, 39046–39052 (2001).
Tritsch, N. X., Yi, E., Gale, J. E., Glowatzki, E. & Bergles, D. E. The origin of spontaneous activity in the developing auditory system. Nature 450, 50–55 (2007).
Zuo, J. & Rarey, K. Responsiveness of α1 and β1 cochlear Na, K-ATPase isoforms to thyroid hormone. Acta Otolaryngol. (Stockh.) 116, 422–428 (1996).
Ruiz-Marcos, A., Salas, J., Sanchez-Toscano, F., Escobar del Rey, F. & Morreale de Escobar, G. Effect of neonatal and adult-onset hypothyroidism on pyramidal cells of the rat auditory cortex. Dev. Brain Res. 9, 205–213 (1983).
Guadaño-Ferraz, A., Escámez, M., Rausell, E. & Bernal, J. Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory neurons. J. Neurosci. 19, 3430–3439 (1999).
Bok, J., Chang, W. & Wu, D. K. Patterning and morphogenesis of the vertebrate inner ear. Int. J. Dev. Biol. 51, 521–533 (2007).
Fisher, D. in Werner and Ingbar's The Thyroid (eds Braverman, L. E. & Utiger, R. D.) 974–983 (Lippincott-Raven, USA, 1996).
Ng, L. et al. A protective role for type 3 deiodinase, a thyroid hormone-inactivating enzyme, in cochlear development and auditory function. Endocrinology 150, 1952–1960 (2009).
Ng, L. et al. Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc. Natl Acad. Sci. USA 101, 3474–3479 (2004).
Kaplan, M. M. & Yaskoski, K. A. Maturational patterns of iodothyronine phenolic and tyrosyl ring deiodinase activities in rat cerebrum, cerebellum, and hypothalamus. J. Clin. Invest. 67, 1208–1214 (1981).
Bates, J. M., St Germain, D. L. & Galton, V. A. Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 140, 844–851 (1999).
Kester, M. H. et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J. Clin. Endocrinol. Metab. 89, 3117–3128 (2004).
Freeman, S., Cherny, L. & Sohmer, H. Thyroxine affects physiological and morphological development of the ear. Hear. Res. 97, 19–29 (1996).
Visser, W. E., Friesema, E. C., Jansen, J. & Visser, T. J. Thyroid hormone transport in and out of cells. Trends Endocrinol. Metab. 19, 50–56 (2008).
Sharlin, D. S., Visser, T. J. & Forrest, D. Developmental and cell-specific expression of thyroid hormone transporters in the mouse cochlea. Endocrinology 152, 5053–5064 (2011).
Nakashima, T. et al. Disorders of cochlear blood flow. Brain Res. Brain Res. Rev. 43, 17–28 (2003).
Knipper, M. et al. Thyroid hormone affects Schwann cell and oligodendrocyte gene expression at the glial transition zone of the VIIIth nerve prior to cochlea function. Development 125, 3709–3718 (1998).
Berbel, P., Obregon, M. J., Bernal, J., Escobar del Rey, F. & Morreale de Escobar, G. Iodine supplementation during pregnancy: a public health challenge. Trends Endocrinol. Metab. 18, 338–343 (2007).
Rajatanavin, R. et al. Endemic cretinism in Thailand: a multidisciplinary survey. Eur. J. Endocrinol. 137, 349–355 (1997).
Soriguer, F. et al. The auditory threshold in a school-age population is related to iodine intake and thyroid function. Thyroid 10, 991–999 (2000).
Abrams, G. M. & Larsen, P. R. Triiodothyronine and thyroxine in the serum and thyroid glands of iodine-deficient rats. J. Clin. Invest. 52, 2522–2531 (1973).
Yasuda, T. et al. Outcome of a baby born from a mother with acquired juvenile hypothyroidism having undetectable thyroid hormone concentrations. J. Clin. Endocrinol. Metab. 84, 2630–2632 (1999).
Wasserman, E. E. et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am. J. Epidemiol. 167, 701–710 (2008).
Harris, K. B. & Pass, K. A. Increase in congenital hypothyroidism in New York State and in the United States. Mol. Genet. Metab. 91, 268–277 (2007).
LaFranchi, S. H. Approach to the diagnosis and treatment of neonatal hypothyroidism. J. Clin. Endocrinol. Metab. 96, 2959–2967 (2011).
Vanderschueren-Lodeweyckx, M., Debruyne, F., Dooms, L., Eggermont, E. & Eeckels, R. Sensorineural hearing loss in sporadic congenital hypothyroidism. Arch. Dis. Child. 58, 419–422 (1983).
Francois, M., Bonfils, P., Leger, J., Czernichow, P. & Narcy, P. Role of congenital hypothyroidism in hearing loss in children. J. Pediatr. 124, 444–446 (1994).
Rovet, J., Walker, W., Bliss, B., Buchanan, L. & Ehrlich, R. Long-term sequelae of hearing impairment in congenital hypothyroidism. J. Pediatr. 128, 776–783 (1996).
Parazzini, M. et al. Click-evoked otoacoustic emissions recorded from untreated congenital hypothyroid newborns. Hear. Res. 166, 136–142 (2002).
Wasniewska, M. et al. Hearing loss in congenital hypothalamic hypothyroidism: a wide therapeutic window. Hear. Res. 172, 87–91 (2002).
Groenhout, E. G. & Dorin, R. I. Generalized thyroid hormone resistance due to a deletion of the carboxy terminus of the c-erbA beta receptor. Mol. Cell Endocrinol. 99, 81–88 (1994).
Phillips, S. A. et al. Extreme thyroid hormone resistance in a patient with a novel truncated TR mutant. J. Clin. Endocrinol. Metab. 86, 5142–5147 (2001).
Guenther, M. G. et al. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40- repeat protein linked to deafness. Genes Dev. 14, 1048–1057 (2000).
Ono, S. et al. Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 73, 990–994 (1991).
Frank-Raue, K. et al. Severe form of thyroid hormone resistance in a patient with homozygous/hemizygous mutation of T3 receptor gene. Eur. J. Endocrinol. 150, 819–823 (2004).
Dumitrescu, A. M. et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat. Genet. 37, 1247–1252 (2005).
Azevedo, M. F. et al. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J. Clin. Endocrinol. Metab. 95, 4066–4071 (2010).
Schoenmakers, E. et al. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J. Clin. Invest. 120, 4220–4235 (2010).
Hamajima, T., Mushimoto, Y., Kobayashi, H., Saito, Y. & Onigata, K. Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation. Eur. J. Endocrinol. 166, 757–764 (2012).
Dumitrescu, A. M., Liao, X. H., Best, T. B., Brockmann, K. & Refetoff, S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am. J. Hum. Genet. 74, 168–175 (2004).
Friesema, E. C. et al. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364, 1435–1437 (2004).
Wirth, E. K. et al. Neuronal 3′,3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J. Neurosci. 29, 9439–9449 (2009).
Griffith, A. J. & Wangemann, P. Hearing loss associated with enlargement of the vestibular aqueduct: mechanistic insights from clinical phenotypes, genotypes, and mouse models. Hear. Res. 281, 11–17 (2011).
Fang, Q. et al. A modifier gene alleviates hypothyroidism-induced hearing impairment in Pou1f1dw dwarf mice. Genetics 189, 665–673 (2011).
Fang, Q., Giordimaina, A. M., Dolan, D. F., Camper, S. A. & Mustapha, M. Genetic background of Prop1(df) mutants provides remarkable protection against hypothyroidism-induced hearing impairment. J. Assoc. Res. Otolaryngol. 13, 173–184 (2012).
Guo, T. W. et al. Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J. Med. Genet. 41, 585–590 (2004).
Schomburg, L. Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat. Rev. Endocrinol. 8, 160–171 (2012).
Newell, F. W. & Diddie, K. R. Typical monochromacy, congenital deafness, and resistance to intracellular action of thyroid hormone. Klin. Monatsbl. Augenheilkd. 171, 731–734 (1977).
Lindstedt, G., Lundberg, P. A., Sjogren, B., Ernest, I. & Sundquist, O. Thyroid hormone resistance in a 35-year old man with recurrent goitre. Scand. J. Clin. Lab. Invest. 42, 585–593 (1982).
Weiss, A. H., Kelly, J. P., Bisset, D. & Deeb, S. S. Reduced L- and M- and increased S-cone functions in an infant with thyroid hormone resistance due to mutations in the THRβ2 gene. Ophthalmic Genet. 33, 187–195 (2012).
Ng, L. et al. Type 3 deiodinase, a thyroid-hormone-inactivating enzyme, controls survival and maturation of cone photoreceptors. J. Neurosci. 30, 3347–3357 (2010).
Mirabella, G. et al. Development of contrast sensitivity in infants with prenatal and neonatal thyroid hormone insufficiencies. Pediatr. Res. 57, 902–907 (2005).
Simic, N., Westall, C., Astzalos, E. V. & Rovet, J. Visual abilities at 6 months in preterm infants: impact of thyroid hormone deficiency and neonatal medical morbidity. Thyroid 20, 309–315 (2010).
Esaki, T. et al. Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors. Endocrinology 144, 4117–4122 (2003).
Freeman, S. & Sohmer, H. Effect of thyroxine on the development of somatosensory and visual evoked potentials in the rat. J. Neurol. Sci. 128, 143–150 (1995).
Auso, E. et al. Protracted expression of serotonin transporter and altered thalamocortical projections in the barrelfield of hypothyroid rats. Eur. J. Neurosci. 14, 1968–1980 (2001).
Laureau, E. et al. Somatosensory evoked potentials and auditory brain-stem responses in congenital hypothyroidism. I. A longitudinal study before and after treatment in six infants detected in the neonatal period. Electroencephalogr. Clin. Neurophysiol. 64, 501–510 (1986).
Bongers-Schokking, C. J., Colon, E. J., Hoogland, R. A., de Groot, C. J. & Van den Brande, J. L. Somatosensory evoked potentials in neonates with primary congenital hypothyroidism during the first week of therapy. Pediatr. Res. 30, 34–39 (1991).
Calzà, L., Forrest, D., Vennström, B. & Hökfelt, T. Expression of peptides and other neurochemical markers in hypothalamus and olfactory bulb of mice devoid of all known thyroid hormone receptors. Neuroscience 101, 1001–1012 (2000).
Paternostro, M. A. & Meisami, E. Essential role of thyroid hormones in maturation of olfactory receptor neurons: an immunocytochemical study of number and cytoarchitecture of OMP-positive cells in developing rats. Int. J. Dev. Neurosci. 14, 867–880 (1996).
Paternostro, M. A. & Meisami, E. Marked restoration of density and total number of mature (knob-bearing) olfactory receptor neurons in rats recovering from early hypothyroid-induced growth retardation. Brain Res. Dev. Brain Res. 96, 173–183 (1996).
McConnell, R. J., Menendez, C. E., Smith, F. R., Henkin, R. I. & Rivlin, R. S. Defects of taste and smell in patients with hypothyroidism. Am. J. Med. 59, 354–364 (1975).
Gordon, B. H., Wong, G. Y., Liu, J. & Rivlin, R. S. Abnormal taste preference for saccharin in hypothyroid rats. Physiol. Behav. 52, 385–388 (1992).
Marsh-Armstrong, N., Huang, H., Remo, B. F., Liu, T. T. & Brown, D. D. Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase. Neuron 24, 871–878 (1999).
Reiss, J. O. & Burd, G. D. Cellular and molecular interactions in the development of the Xenopus olfactory system. Semin. Cell Dev. Biol. 8, 171–179 (1997).
Allison, W. T., Dann, S. G., Veldhoen, K. M. & Hawryshyn, C. W. Degeneration and regeneration of ultraviolet cone photoreceptors during development in rainbow trout. J. Comp. Neurol. 499, 702–715 (2006).
Lema, S. C. & Nevitt, G. A. Evidence that thyroid hormone induces olfactory cellular proliferation in salmon during a sensitive period for imprinting. J. Exp. Biol. 207, 3317–3327 (2004).
Crofton, K. M. Developmental disruption of thyroid hormone: correlations with hearing dysfunction in rats. Risk Anal. 24, 1665–1671 (2004).
Poon, E., Powers, B. E., McAlonan, R. M., Ferguson, D. C. & Schantz, S. L. Effects of developmental exposure to polychlorinated biphenyls and/or polybrominated diphenyl ethers on cochlear function. Toxicol. Sci. 124, 161–168 (2011).
Haddow, J. E. et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341, 549–555 (1999).
Lazarus, J. H. et al. Antenatal thyroid screening and childhood cognitive function. N. Engl. J. Med. 366, 493–501 (2012).
Brent, G. A. The debate over thyroid-function screening in pregnancy. N. Engl. J. Med. 366, 562–563 (2012).
Pujol, R., Lavigne-Rebillard, M. & Lenoir, M. in Development of the auditory system (eds Rubel, E. W., Popper, A. N. & Fay, R. R) 146–192 (Springer, Germany, 1997).
Acknowledgements
The authors acknowledge the support of the intramural research program at the National Institute of Diabetes and Digestive and Kidney Diseases and at the National Institute on Deafness and other Communication Disorders. The authors thank Dr Francesco Celi for helpful comments.
Author information
Authors and Affiliations
Contributions
All authors contributed equally to all aspects of the article.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ng, L., Kelley, M. & Forrest, D. Making sense with thyroid hormone—the role of T3 in auditory development. Nat Rev Endocrinol 9, 296–307 (2013). https://doi.org/10.1038/nrendo.2013.58
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2013.58
This article is cited by
-
Thyroid hormone-regulated chromatin landscape and transcriptional sensitivity of the pituitary gland
Communications Biology (2023)
-
Exacerbated age-related hearing loss in mice lacking the p43 mitochondrial T3 receptor
BMC Biology (2021)
-
TBL1Y: a new gene involved in syndromic hearing loss
European Journal of Human Genetics (2019)
-
Genetic variation in thyroid folliculogenesis influences susceptibility to hypothyroidism-induced hearing impairment
Mammalian Genome (2019)
-
Deafness and loss of cochlear hair cells in the absence of thyroid hormone transporters Slc16a2 (Mct8) and Slc16a10 (Mct10)
Scientific Reports (2018)